Tag: Trust in pharma
Latest articles
Junk DNA affects inherited cancer risk: New research
A new study published in the British Journal of Cancer shows that inherited cancer risk is not only affected by mutations in key cancer...
Half of WHO-recommended policies to reduce chronic diseases are not put into practice
The first analysis of WHO-recommended policies to reduce chronic diseases finds that implementation is slowly improving, but on average just over half get no...
New global survey shows public perceptions of lung cancer
New global survey shows public perceptions of lung cancer and also highlights that people believe that prognoses for the disease are dire, and there...
Popular articles
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
Novartis highlights progress in R&D pipeline
Novartis is holding an investor event to provide a comprehensive overview of the company’s progress in advancing its R&D pipeline. Key highlights to be presented...
Pharmaceutical direct-to-consumer advertising in Europe
DTCA provides a favourable environment for shared decision-making wherein the patient is aware of the risks and benefits of new drugs. It also addresses...
Google or GP: Who Does the Public Trust More?
Ramya Sriram, Content and Communications Specialist at Kolabtree, looks how new research considers where the public goes for medical information and how they can...
How to be a successful key account manager
Pf asked two consultants from top pharma recruitment consultancies for their views on what it takes to be a successful key account manager.
Andy Boyd, Senior...